237 related articles for article (PubMed ID: 38059844)
1. [Cognitive impairment and the blood-brain barrier in chronic kidney disease: role of the uremic toxins].
Bobot M
Nephrol Ther; 2023 Dec; 19(7):607-615. PubMed ID: 38059844
[TBL] [Abstract][Full Text] [Related]
2. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier perturbations by uremic toxins: Key contributors in chronic kidney disease-induced neurological disorders?
Faucher Q; van der Made TK; De Lange E; Masereeuw R
Eur J Pharm Sci; 2023 Aug; 187():106462. PubMed ID: 37169097
[TBL] [Abstract][Full Text] [Related]
4. Emotional and cognitive changes in chronic kidney disease.
Kim DS; Kim SW; Gil HW
Korean J Intern Med; 2022 May; 37(3):489-501. PubMed ID: 35249316
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
Liabeuf S; Pepin M; Franssen CFM; Viggiano D; Carriazo S; Gansevoort RT; Gesualdo L; Hafez G; Malyszko J; Mayer C; Nitsch D; Ortiz A; Pešić V; Wiecek A; Massy ZA;
Nephrol Dial Transplant; 2021 Dec; 37(Suppl 2):ii33-ii44. PubMed ID: 34718753
[TBL] [Abstract][Full Text] [Related]
6. The specific impact of uremic toxins upon cognitive domains: a review.
Franco ÁO; Starosta RT; Roriz-Cruz M
J Bras Nefrol; 2019; 41(1):103-111. PubMed ID: 30095142
[TBL] [Abstract][Full Text] [Related]
7. Chronic kidney disease promotes cerebral microhemorrhage formation.
Fang C; Lau WL; Sun J; Chang R; Vallejo A; Lee D; Liu J; Liu H; Hung YH; Zhao Y; Paganini-Hill A; Sumbria RK; Cribbs DH; Fisher M
J Neuroinflammation; 2023 Feb; 20(1):51. PubMed ID: 36841828
[TBL] [Abstract][Full Text] [Related]
8. Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis.
Wakamatsu T; Yamamoto S; Yoshida S; Narita I
Toxins (Basel); 2024 May; 16(6):. PubMed ID: 38922148
[TBL] [Abstract][Full Text] [Related]
9. Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight.
Chao CT; Lin SH
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200937
[TBL] [Abstract][Full Text] [Related]
10. Cerebro-renal interactions: impact of uremic toxins on cognitive function.
Watanabe K; Watanabe T; Nakayama M
Neurotoxicology; 2014 Sep; 44():184-93. PubMed ID: 25003961
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
Yamamoto S
Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
[TBL] [Abstract][Full Text] [Related]
12. P
Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
[TBL] [Abstract][Full Text] [Related]
13. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
Wu CL; Tarng DC
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease.
Fourdinier O; Glorieux G; Brigant B; Diouf M; Pletinck A; Vanholder R; Choukroun G; Verbeke F; Massy ZA; Metzinger-Le Meuth V; Metzinger L; Group-EUTox OBOTEUTW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638892
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
[TBL] [Abstract][Full Text] [Related]
16. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
17. Association between Dental Scores and Saliva Uremic Toxins.
Rigothier C; Catros S; Bénard A; Samot J; Quintin O; Combe C; Larabi I; Massy Z; Alvarez JC
Toxins (Basel); 2023 Nov; 15(11):. PubMed ID: 37999529
[TBL] [Abstract][Full Text] [Related]
18. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
[TBL] [Abstract][Full Text] [Related]
19. AST-120 to Target Protein-Bound Uremic Toxins Improves Cardiac Output and Kidney Oxygenation in Experimental Chronic Kidney Disease.
Sivertsson E; Ceder S; Nangaku M; Hansell P; Nordquist L; Palm F
Kidney Blood Press Res; 2023; 48(1):114-123. PubMed ID: 36791683
[TBL] [Abstract][Full Text] [Related]
20. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
